Risk of hepatitis B virus-related hepatocellular carcinoma development is much higher in Koreans than in Taiwanese
Jae-Jun Shim, Jung Wook Kim, Byung-Ho Kim
Korean J Intern Med. 2017;32(5):940-942. Published online 2017 Jul 7 DOI: https://doi.org/10.3904/kjim.2016.180
Citations to this article as recorded by 
Comment on: Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study
Chien-Hsiang Weng, Philip A. Chan, Joseph Magagnoli, Charles L. Bennett
Drug Safety.2025;[Epub] CrossRef
Factors associated with TDF-to-TAF switching in chronic hepatitis B: A nationwide cohort study in South Korea
Hyemin Ha, Kwang Il Seo, Nam Kyung Je
Journal of Infection and Chemotherapy.2025; 31(12): 102860. CrossRef
High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation
Gwang Hyeon Choi, Gi‐Ae Kim, Jonggi Choi, Seungbong Han, Young‐Suk Lim
Alimentary Pharmacology & Therapeutics.2019; 50(2): 215. CrossRef